ESPR
Price:
$2.52
Market Cap:
$496.53M
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-06-26
Stock Exchange
NASDAQ
Ticker
ESPR
According to Esperion Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Esperion Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), ESPR's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Esperion Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
2014 | 0% | 0% |
The current Dividend Yield of Esperion Therapeutics, Inc. (ESPR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Esperion Therapeutics, Inc.’s Dividend Yield is less than Elanco Animal Health Incorporated (0%), less than SIGA Technologies, Inc. (9.26%), less than Indivior PLC (0%), less than Catalent, Inc. (0%), less than Eagle Pharmaceuticals, Inc. (0%), less than ANI Pharmaceuticals, Inc. (0%), less than Phibro Animal Health Corporation (2.02%), less than Deciphera Pharmaceuticals, Inc. (0%), less than Prestige Consumer Healthcare Inc. (0%), less than Collegium Pharmaceutical, Inc. (0%), less than Pacira BioSciences, Inc. (0%), less than Intra-Cellular Therapies, Inc. (0%), less than Alkermes plc (0%), less than Neurocrine Biosciences, Inc. (0%), less than Ironwood Pharmaceuticals, Inc. (0%), less than Avadel Pharmaceuticals plc (0%), less than Lifecore Biomedical, Inc. (0%), less than Rockwell Medical, Inc. (0%), less than Kamada Ltd. (0%), less than Agile Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $6.60B | |
9.26% | $462.70M | |
0% | $3.01B | |
0% | $11.07B | |
0% | $12.31M | |
0% | $1.20B | |
2.02% | $961.56M | |
0% | $2.21B | |
0% | $4.19B | |
0% | $966.22M | |
0% | $810.34M | |
0% | $9.08B | |
0% | $4.66B | |
0% | $12.72B | |
0% | $550.50M | |
0% | $1.12B | |
0% | $269.21M | |
0% | $72.72M | |
0% | $337.44M | |
0% | $10.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Esperion Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Esperion Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Esperion Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Esperion Therapeutics, Inc. (ESPR)?
What is the highest Dividend Yield for Esperion Therapeutics, Inc. (ESPR)?
What is the 3-year average Dividend Yield for Esperion Therapeutics, Inc. (ESPR)?
What is the 5-year average Dividend Yield for Esperion Therapeutics, Inc. (ESPR)?
How does the current Dividend Yield for Esperion Therapeutics, Inc. (ESPR) compare to its historical average?